NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
6.95
-0.45 (-6.08%)
At close: Sep 25, 2026, 4:00 PM EDT
7.07
+0.12 (1.71%)
After-hours: Sep 25, 2026, 7:37 PM EDT
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $12.85 million as of September 25, 2026. Its market cap has decreased by -58.63% in one year.
Market Cap
12.85M
Enterprise Value
12.85M
1-Year Change
-58.63%
Ranking
Category
Stock Price
$6.95
ChartMarket Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $12.85M, a decrease of -80.11%. That is a compound annual growth rate of -28.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 12.85M | -43.74% |
| Dec 31, 2025 | 22.84M | -17.70% |
| Dec 31, 2024 | 27.75M | 158.68% |
| Dec 29, 2023 | 10.73M | -24.68% |
| Dec 30, 2022 | 14.24M | -46.24% |
| Dec 31, 2021 | 26.49M | -59.00% |
| Dec 9, 2021 | 64.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Niki BioSolutions | 13.99M |
| Tempest Therapeutics | 13.71M |
| AEON Biopharma | 13.15M |
| Pluri | 12.47M |
| GT Biopharma | 12.43M |
| Intensity Therapeutics | 12.41M |
| Vistagen Therapeutics | 12.11M |
| BioVie | 12.11M |